News
Alexza Pharmaceuticals Receives EU Certificate of GMP Compliance for its ADASUVEâ„¢ Manufacturing Fa
Alexza Pharmaceuticals, Inc. announced today that the company has received its EU Certificate of GMP Compliance of a Manufacturer. In May 2012, Alexza hosted an...
News
Segasist launches Crowd-Funding Round for Cloud-Based Quality Assurance in Cancer Treatment
Segasist Technologies, a Canadian software company developing next-generation image contouring platforms for biomedical applications, has launched a crowd funding campaign to bring its software Reconcillio...
News
Stanford University Releases Statement Reiterating Its Long-Standing Relationship With Nu Skin Enter
Nu Skin Enterprises, Inc. reiterated its research relationship with Stanford University and announced that Stanford today issued the following release, which stated, "The Department of...
News
Professors Produce First Comprehensive Collection Of Academic Literature On Addictive Properties Of
Can certain foods hijack the brain in ways similar to drugs and alcohol, and is this effect sufficiently strong to contribute to major diseases such...
News
Actinium Pharmaceuticals and Philogen S.p.A. Announce Collaboration for Alpha Therapy Based Antiangi
Actinium Pharmaceuticals, Inc. and Philogen S.p.A today announced that they have entered into a collaboration agreement under which the companies will explore feasibility and best...
News
PAREXEL Strengthens Outcomes Research Capabilities To Help Biopharma Meet Commercialization Goals
 PAREXEL Consulting, a business unit of PAREXEL International and a leading global consultancy serving the biopharmaceutical and medical device industries, today announced that Leanne...
News
Ampio announces successful Pre-IND meeting with the Ophthalmology Division of the FDA on Optinaa
Ampio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing drugs for the treatment of inflammation, eye disease, kidney disease, CNS disease, metabolic disease and male...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
